<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR191">
 <label>191.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brahmer</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Hammers</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Lipson</surname>
    <given-names>EJ</given-names>
   </name>
  </person-group>
  <article-title>Nivolumab: targeting PD-1 to bolster antitumor immunity</article-title>
  <source>Future Oncol</source>
  <year>2015</year>
  <volume>11</volume>
  <fpage>1307</fpage>
  <lpage>1326</lpage>
  <pub-id pub-id-type="doi">10.2217/fon.15.52</pub-id>
  <?supplied-pmid 25798726?>
  <pub-id pub-id-type="pmid">25798726</pub-id>
 </element-citation>
</ref>
